Protocol for the Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) study: A cluster randomised controlled trial using ePrescribing data

BMJ Open

Volumn 2, Issue 6, 2012, Pages

  Guthrie, Bruce ^a   Treweek, Shaun ^a   Petrie, Dennis ^a   Barnett, Karen ^b   Ritchie, Lewis D ^c   Robertson, Chris ^d   Bennie, Marion ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; METHOTREXATE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; VERAPAMIL;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GENDER; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HUMAN; PHARMACIST; PRESCRIPTION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 84873810854     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002359     Document Type: Article

References (33)

1. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004;329:15-19. (Pubitemid 38869995)
2. Howard R, Avery A, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47. (Pubitemid 46072098)
3. Avery A, Barber N, Ghaleb MA, et al. Investigating the prevalence and causes of prescribing errors in general practice: the PRACtICe study. Nottingham: University of Nottingham, 2012.
4. National Patient Safety Agency. Improving compliance with oral methotrexate guidelines. 2006. http://www.npsa.nhs.uk/nrls/alerts-and- directives/alerts/oral-methotrexate/ (accessed 6 December 2012).
5. Medicines and Healthcare products Regulatory Agency and Commission on Human Medicines. Antipsychotics: use in elderly people with dementia. Drug Safety Update 2009;2.
6. Higashi T, Shekelle P, Solomon DH, et al. The quality of pharmacological care for vulnerable older patients. Arch Intern Med 2004;140:714-20.
7. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008;37:673-9.
8. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers Criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003;163:2716-24. (Pubitemid 37517412)
9. Dreischulte T, Grant A, McCowan C, et al. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol 2012;12:5.
10. Guthrie B, McCowan C, Davey P, et al. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011;342:d3514.
11. Jamtvedt G, Young JM, Kristoffersen DT, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 1998;(1):CD000259, 2006.
12. Foy R, Eccles M, Jamtvedt G, et al. What do we know about how to do audit and feedback? Pitfalls in applying evidence from a systematic review. BMC Health Services Research 2005;5:50.
13. Kiefe C, Allison J, Williams O, et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 2001;285:2871-9. (Pubitemid 32537351)
14. Hysong SJ, Best R, Pugh J. Audit and feedback and clinical practice guideline adherence: making feedback actionable. Implement Sci 2006;1:9.
15. Hysong SJ. Meta-analysis: audit and feedback features impact effectiveness on care quality. Med Care 2009;47:356-63.
16. Azjen I, Fishbein M. Questions raised by a reasoned action approach: comment on Ogden (2003). Health Psychol 2004;23:431-4. (Pubitemid 38880177)
17. Schwarzer R. Self-efficacy in the adoption and maintenance of health behaviors: theoretical approaches and a new model. In: Schwarzer R, ed. Self-efficacy: thought control of action. Washington, DC: Hemisphere, 1992:217-42.
18. Michie S, Johnston M, Francis J, et al. From theory to intervention: mapping theoretically derived behavioural determinants to behaviour change techniques. Appl Psychol Int Rev 2008;57:660-80.
19. Avery AJ, Dex GM, Mulvaney C, et al. Development of prescribing-safety indicators for GPs using the RAND appropriateness method. Br J Gen Pract 2011;61:e526-36.
20. Banerjee S. The use of antipsychotic medication for people with dementia: time for action. London: Department of Health, 2009.
21. Department of Health. Government response to Professor Sube Banerjee's report on the prescribing of anti-psychotic drugs to people with dementia. London: Department of Health, 2009.
22. Thomas M. Diuretics, ACE inhibitors and NSAIDs - the triple whammy. Med J Aust 2000;172:184-5.
23. Loboz K, Shenfield G. Drug combinations and impaired renal function - the 'triple whammy'. Br J Clin Pharmacol 2005;59:239-43. (Pubitemid 40208862)
24. NHS National Prescribing Centre. Cardiovascular and gastrointestinal safety of NSAIDs, MeReC Extra 2007;30.
25. NHS National Prescribing Centre. Important updates on drug safety from the MHRA/CHM, MeReC Monthly 2009;16.
26. MacDonald TM, Morant S, Robinson G, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997;315:1333.
27. Delaney JAM, Opatrny LMDM, Brophy JMMDP, et al. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. Can Med Assoc J 2007;177:347-51.
28. NHS National Prescribing Centre. Update on the prescribing of NSAIDs. MeReC Monthly No 2 2008.
29. Donnar A, Klar N. Design and analysis of cluster randomization trials in health research. London: Arnold, 2000.
30. Rotondi M. CRTSize version 0.2 Sample Size Estimation Functions for Cluster Randomized Trials. http://cran.r-project.org/web/packages/CRTSize/index. html. 2011 (accessed 6 December 2012).
31. Office of the Chief Statistician. Scottish index of multiple deprivation 2004 summary technical report. Edinburgh: Scottish Executive, 2004.
32. Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012;379:1310-9.
33. Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012;(6)::CD000259.